Improved survival of ischemic random skin flaps through the use of bone marrow nonhematopoietic stem cells and angiogenic growth factors

Annals of Plastic Surgery

Volumn 54, Issue 5, 2005, Pages 546-552

  Simman, Richard ^a,b   Craft, Chris ^a   McKinney, Bart ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Angiogenic factors; Precursor cells; Skin flaps; Stem cells

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; PLASTIC; RECOMBINANT VASCULOTROPIN; RESIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; EUTHANASIA; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; ISCHEMIA; NECROSIS; NONHUMAN; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; SKIN FLAP; TISSUE FLAP; TREATMENT OUTCOME; VASCULARIZATION; WOUND CARE;

ANGIOPOIETIN-1; ANIMALS; ISCHEMIA; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RISK FACTORS; SKIN; STEM CELL TRANSPLANTATION; SURGICAL FLAPS; TISSUE SURVIVAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 17644367476     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000158068.86576.73     Document Type: Article

References (29)

1. Morris SF, Taylor GI. The time sequence of the delay phenomenon: when is surgical delay effective? An experimental study. Plast Reconstr Surg. 1995;95:526.
2. Li QF, Reis ED, Zhang WX, et al. Accelerated flap prefabrication with vascular endothelial growth factor. J Reconstr Microsurg. 2000;16:45.
3. Zang F, Fischer K, Komorowska-Timek E, et al. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg. 2001;46:314.
4. Taran A, Har-Shari Y, Lindenbaum E, et al. Improved vitality of experimental random dorsal skin flaps in rats treated with enriched cell culture medium. Plast Reconstr Surg. 1999;104:148.
5. Nakano M, Nakajima Y, Kudo S, et al. Effect of autotransplantation of microvessel fragments on experimental random-pattern flaps in the rat. Eur Surg Res. 1998;30:149.
6. Amir A, Solomon AS, Giler S, et al. The influence of helium-neon laser irradiation on the viability of skin flaps. Br J Plast Surg. 2000;53:58.
7. Patel C, Marsili A, Sykes PJ. Augmentation of flap survival by thymoxamine. Br J Plast Surg. 1982;35:88.
8. Finseth F, Adelberg MG. Prevention of skin flap necrosis by a course of treatment with vasodilator drugs. Plast Reconstr Surg. 1978;61:738.
9. Joshua G, Menachem RW, Isaac JP. The use of two alpha blocking agents, phenoxybenzamine and phentolamine, in ointment and injection form to improve skin flap survival in rats. Ann Plast Surg. 1985;15:431.
10. Aker JS, Mancoll J, Lewis B, et al. The effects of pentoxifylline on random pattern skin flap necrosis induced by nicotine treatment in the rat. Plast Reconstr Surg. 1997;100:66.
11. Rohrich RJ, Cherry GW, Spira M. Enhancement of skin flap survival using nitroglycerin ointment. Plast Reconstr Surg. 1984;73:943.
12. Price MA, Pearl RM. Multiagent pharmacotherapy to enhance skin flap survival: lack of additive effect of nitroglycerin and allopurinol. Ann Plast Surg. 1994;33:52.
13. Vedder NB, Bucky LP, Richey NL, et al. Improved survival rates of random flaps in rabbits with a monoclonal antibody that blocks leukocyte adherence. Plast Reconstr Surg. 1994;93:1035.
14. Tepper OM, Galiano RD, Kalka C, et al. Endothelial progenitor cells: the promise of vascular stem cells for plastic surgery. Plast Reconstr Surg. 2003;111:846.
15. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;75:964.
16. Darwin JP. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:309.
17. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs. 2001;25:187-193.
18. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science. 2000;288:1660.
19. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993;73:713.
20. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221.
21. Sanghoon P, Tepper OM, Galiano RD, et al. Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast Reconstr Surg. 2004;113:284.
22. Kalka C, Tehrani H, Laudenberg B, et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with operable coronary disease. Ann Thorac Surg. 2000;70:829.
23. Kalka C, Takahashi T, Masuda H, et al. VEGF: therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease. Med Klin. 1999;94:193.
24. Kalka C, Masuda H, Takahashi T, et al. VEGF(165) gene transfer augments circulating endothelial progenitors cells in human subjects. Circ Res. 2000;86:1198.
25. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitors cells. EMBO J. 1999;18:3964.
26. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-30.
27. Yoshiaki K, Kazuo K, Hiroko S, et al. Transplanted endothelial progenitor cells augment the survival areas of rat dorsal flaps. Cell Transplant. 2003;12:647.
28. Satoshi S, Toyoaki M, Hisao I, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 2001; 103:897.
29. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve. 1995;18:1417.